NCT03534804 2024-11-26
PemCab
University of Utah
Phase 2 Completed
Clinical Trials
4 trialsNCT02795156 2023-12-05
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
SCRI Development Innovations, LLC
Phase 2 Completed
NCT04173338 2022-06-14
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
Augusta University
Phase 1 Terminated
NCT04066595 2021-08-30
CabUC
Johannes Gutenberg University Mainz
Phase 2 Terminated